Resistance to erythropoiesis-stimulating agents among patients on hemodialysis is typically transient
Introduction: This study examines factors associated with erythropoiesis-stimulating agent
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
[PDF][PDF] Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
DAGJZ Aleix, CM Nangakuc, A Karaboyasa - Am J Nephrol, 2022 - d-nb.info
Introduction: This study examines factors associated with erythropoiesis-stimulating agent
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
DA Goodkin, J Zhao, A Cases, M Nangaku… - American Journal of …, 2022 - europepmc.org
Methods We used international Dialysis Outcomes and Practice Patterns Study data from
2015 to 2018 (N= 26,656) to investigate changes in ESA Resistance Index (ERI), calculated …
2015 to 2018 (N= 26,656) to investigate changes in ESA Resistance Index (ERI), calculated …
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
DA Goodkin, J Zhao, A Cases… - American Journal of …, 2022 - search.ebscohost.com
Introduction: This study examines factors associated with erythropoiesis-stimulating agent
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
DA Goodkin, J Zhao, A Cases… - American journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction This study examines factors associated with erythropoiesis-stimulating agent
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
[HTML][HTML] Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
DA Goodkin, J Zhao, A Cases, M Nangaku… - American Journal of … - ncbi.nlm.nih.gov
Methods We used international Dialysis Outcomes and Practice Patterns Study data from
2015 to 2018 (N= 26,656) to investigate changes in ESA Resistance Index (ERI), calculated …
2015 to 2018 (N= 26,656) to investigate changes in ESA Resistance Index (ERI), calculated …
[HTML][HTML] Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
DA Goodkin, J Zhao, A Cases, M Nangaku… - American Journal of …, 2022 - karger.com
Introduction: This study examines factors associated with erythropoiesis-stimulating agent
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
DA Goodkin, J Zhao, A Cases, M Nangaku… - American Journal of …, 2022 - go.gale.com
Introduction: This study examines factors associated with erythropoiesis-stimulating agent
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
(ESA) hyporesponsiveness, the duration of ESA hyporesponsiveness, the frequency of new …
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
DA Goodkin, J Zhao, A Cases, M Nangaku… - American Journal of …, 2022 - europepmc.org
Methods We used international Dialysis Outcomes and Practice Patterns Study data from
2015 to 2018 (N= 26,656) to investigate changes in ESA Resistance Index (ERI), calculated …
2015 to 2018 (N= 26,656) to investigate changes in ESA Resistance Index (ERI), calculated …